The epoch times
FDA Approves First US Postpartum Depression Pill: Key Details
The U.S. FDA Approves Groundbreaking Pill for Postpartum Depression
The U.S. Food and Drug Administration (FDA) has made history by granting approval to a revolutionary pill designed to treat postpartum depression. This groundbreaking development brings hope to the millions of mothers affected by this condition.
Previously, treatment options for postpartum depression in the United States were limited to intravenous (IV) injections administered exclusively by healthcare professionals in specific healthcare facilities.
Introducing Zurzuvae, the game-changing pill jointly developed by Biogen and Sage Therapeutics. This innovative medication offers a convenient solution, as it only needs to be taken once a day for a duration of 14 days.
Read More From Original Article Here: FDA Approves First Postpartum Depression Pill in US: What to Know
" Conservative News Daily does not always share or support the views and opinions expressed here; they are just those of the writer."
*As an Amazon Associate I earn from qualifying purchases
Follow Us
